Cigarette smoke mediates epigenetic repression of MIR-217 during esophageal adenocarcinogenesis

Oncogene

Volumn 34, Issue 44, 2015, Pages 5548-5559

  Xi, S ^a   Inchauste, S ^a   Guo, H ^b   Shan, J ^c   Xiao, Z ^d   Xu, H ^d   Miettenen, M ^a   Zhang, M R ^a   Hong, J A ^a   Raiji, M T ^a   Altorki, N K ^e   Casson, A G ^f   Beer, D G ^g   Robles, A I ^a   Bowman, E D ^a   Harris, C C ^a   Steinberg, S M ^a   Schrump, D S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e WEILL CORNELL MEDICAL CENTER   (United States)

^f UNIVERSITY OF SASKATCHEWAN   (Canada)

^g UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE CONDENSATE; DNA METHYLTRANSFERASE 3B; MICRORNA; MICRORNA 217; NUCLEAR FACTOR I; RNA; STRATUM CORNEUM CHYMOTRYPTIC ENZYME; UNCLASSIFIED DRUG; CHROMATIN; KALLIKREIN; KLK7 PROTEIN, HUMAN; MIRN217 MICRORNA, HUMAN; SMOKE;

ADENOCARCINOMA CELL LINE; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA METHYLATION; EPIGENETIC REPRESSION; EPITHELIUM CELL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS MUCOSA; GENE EXPRESSION; GENE INTERACTION; GENE LOCUS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMORTALIZED CELL LINE; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; UPREGULATION; ADENOCARCINOMA; ADVERSE EFFECTS; CELL PROLIFERATION; CHROMATIN; DOWN REGULATION; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; SMOKE; TOBACCO; TUMOR CELL LINE; TUMOR INVASION;

ADENOCARCINOMA; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN; DNA METHYLATION; DOWN-REGULATION; EPIGENETIC REPRESSION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KALLIKREINS; MICRORNAS; NEOPLASM INVASIVENESS; NFI TRANSCRIPTION FACTORS; SMOKE; SMOKING; TOBACCO; UP-REGULATION;

EID: 84946498026     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.10     Document Type: Article

References (44)

1. Agrawal N, Jiao Y, Bettegowda C, Hutfless SM, Wang Y, David S et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov 2012; 2: 899-905.
2. Dulak AM, Schumacher SE, van LJ, Imamura Y, Fox C, Shim B et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res 2012; 72: 4383-4393.
3. Napier KJ, Scheerer M, Misra S. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol 2014; 6: 112-120.
4. Estores D, Velanovich V. Barrett esophagus: epidemiology, pathogenesis, diagnosis, and management. Curr Probl Surg 2013; 50: 192-226.
5. Spechler SJ. Barrett esophagus and risk of esophageal cancer: a clinical review. JAMA 2013; 310: 627-636.
6. Ek WE, Levine DM, D'Amato M, Pedersen NL, Magnusson PK, Bresso F et al. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst 2013; 105: 1711-1718.
7. Carr JS, Zafar SF, Saba N, Khuri FR, El-Rayes BF. Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma. J Gastrointest Cancer 2013; 44: 143-151.
8. David S, Meltzer SJ. MicroRNA involvement in esophageal carcinogenesis. Curr Opin Pharmacol 2011; 11: 612-616.
9. Mathe EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, Schetter AJ et al. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 2009; 15: 6192-6200.
10. Song JH, Meltzer SJ. MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology 2012; 143: 35-47.
11. Mayne GC, Hussey DJ, Watson DI. MicroRNAs and esophageal cancer-implications for pathogenesis and therapy. Curr Pharm Des 2013; 19: 1211-1226.
12. Fassan M, Volinia S, Palatini J, Pizzi M, Baffa R, De BM et al. MicroRNA expression profiling in human Barrett's carcinogenesis. Int J Cancer 2011; 129: 1661-1670.
13. Leidner RS, Ravi L, Leahy P, Chen Y, Bednarchik B, Streppel M et al. The micro- RNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis. Genes Chromosomes Cancer 2012; 51: 473-479.
14. Devetzi M, Trangas T, Scorilas A, Xynopoulos D, Talieri M. Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7KLK14) in colon cancer. Thromb Haemost 2013; 109: 716-725.
15. Dong Y, Tan OL, Loessner D, Stephens C, Walpole C, Boyle GM et al. Kallikreinrelated peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma. Cancer Res 2010; 70: 2624-2633.
16. Xi S, Xu H, Shan J, Tao Y, Hong JA, Inchauste S et al. Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis. J Clin Invest 2013; 123: 1241-1261.
17. Kent WJ. BLAT-The BLAST-like alignment tool. Genome Res 2002; 12: 656-664.
18. Kato M, Putta S, Wang M, Yuan H, Lanting L, Nair I et al. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 2009; 11: 881-889.
19. Kemp CD, Rao M, Xi S, Inchauste S, Mani H, Fetsch P et al. Polycomb repressor complex-2 is a novel target for mesothelioma therapy. Clin Cancer Res 2012; 18: 77-90.
20. Rao M, Chinnasamy N, Hong JA, Zhang Y, Zhang M, Xi S et al. Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer. Cancer Res 2011; 71: 4192-4204.
21. Diaz-Lopez A, Moreno-Bueno G, Cano A. Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. Cancer Manag Res 2014; 6: 205-216.
22. Gu J, Xuan Z. Inferring the perturbed microRNA regulatory networks in cancer using hierarchical gene co-expression signatures. PLoS One 2013; 8: e81032.
23. Hardikar S, Onstad L, Blount PL, Odze RD, Reid BJ, Vaughan TL. The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus. PLoS One 2013; 8: e52192.
24. Tramacere I, La VC, Negri E. Tobacco smoking and esophageal and gastric cardia adenocarcinoma: a meta-analysis. Epidemiology 2011; 22: 344-349.
25. Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst 2010; 102: 1344-1353.
26. Xu E, Gu J, Hawk ET, Wang KK, Lai M, Huang M et al. Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma. Carcinogenesis 2013; 34: 2750-2756.
27. Frankel A, Armour N, Nancarrow D, Krause L, Hayward N, Lampe G et al. Genome-wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosis. Genes Chromosomes Cancer 2014; 53: 324-338.
28. Zhao WG, Yu SN, Lu ZH, Ma YH, Gu YM, Chen J. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis 2010; 31: 1726-1733.
29. Zhang Y, Xie RL, Croce CM, Stein JL, Lian JB, van Wijnen AJ et al. A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci USA 2011; 108: 9863-9868.
30. Zhang Y, Xie RL, Gordon J, LeBlanc K, Stein JL, Lian JB et al. Control of mesenchymal lineage progression by microRNAs targeting skeletal gene regulators Trps1 and Runx2. J Biol Chem 2012; 287: 21926-21935.
31. Su J, Wang Q, Liu Y, Zhong M. miR-217 inhibits invasion of hepatocellular carcinoma cells through direct suppression of E2F3. Mol Cell Biochem 2014; 392: 289-296.
32. Nishioka C, Ikezoe T, Yang J, Nobumoto A, Tsuda M, Yokoyama A. Downregulation of miR-217 correlates with resistance of ph leukemia cells to ABL tyrosine kinase inhibitors. Cancer Sci 2014; 105: 297-307.
33. Shaw JL, Diamandis EP. Distribution of 15 human kallikreins in tissues and biological fluids. Clin Chem 2007; 53: 1423-1432.
34. Johnson SK, Ramani VC, Hennings L, Haun RS. Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin. Cancer 2007; 109: 1811-1820.
35. Grabowska MM, Day ML. Soluble E-cadherin: more than a symptom of disease. Front Biosci (Landmark Ed) 2012; 17: 1948-1964.
36. Ramani VC, Haun RS. Expression of kallikrein 7 diminishes pancreatic cancer cell adhesion to vitronectin and enhances urokinase-type plasminogen activator receptor shedding. Pancreas 2008; 37: 399-404.
37. Ramani VC, Kaushal GP, Haun RS. Proteolytic action of kallikrein-related peptidase produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains. Biochim Biophys Acta 2011; 1813: 1525-1531.
38. Prezas P, Scorilas A, Yfanti C, Viktorov P, Agnanti N, Diamandis E et al. The role of human tissue kallikreins 7 and 8 in intracranial malignancies. Biol Chem 2006; 387: 1607-1612.
39. Mo L, Zhang J, Shi J, Xuan Q, Yang X, Qin M et al. Human kallikrein 7 induces epithelial-mesenchymal transition-like changes in prostate carcinoma cells: a role in prostate cancer invasion and progression. Anticancer Res 2010; 30: 3413-3420.
40. Prezas P, Arlt MJ, Viktorov P, Soosaipillai A, Holzscheiter L, Schmitt M et al. Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells. Biol Chem 2006; 387: 807-811.
41. Talieri M, Mathioudaki K, Prezas P, Alexopoulou DK, Diamandis EP, Xynopoulos D et al. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer. Thromb Haemost 2009; 101: 741-747.
42. Iakovlev V, Siegel ER, Tsao MS, Haun RS. Expression of kallikrein-related peptidase predicts poor prognosis in patients with unresectable pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2012; 21: 1135-1142.
43. Li H, Zhao J, Zhang JW, Huang QY, Huang JZ, Chi LS et al. MicroRNA-217, downregulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation and migration. Neoplasma 2013; 60: 511-515.
44. Xi S, Yang M, Tao Y, Xu H, Shan J, Inchauste S et al. Cigarette smoke induces C/EBP-beta-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells. PLoS One 2010; 5: e13764.